On April 8, 2024, Mr. Richard J. Napolitano, Chief Accounting Officer (Principal Accounting Officer) of Teladoc Health, Inc. (the ?Company?) informed the Company of his decision to resign, effective May 3, 2024, to pursue another career opportunity. Mr. Napolitano?s decision is due to personal reasons and is not a result of any disagreement with the Company on any matter relating to its operations, policies or practices. The Company thanks Mr. Napolitano for his years of service.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 USD | +0.70% | +1.02% | -40.23% |
29/04 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
26/04 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.23% | 2.17B | |
+115.18% | 703M | |
+5.91% | 539M | |
-62.69% | 168M | |
-43.88% | 74.58M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health, Inc. Announces Resignation of Richard J. Napolitano as Chief Accounting Officer, Effective May 3, 2024